News
May 8, 2008
Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration
International study to evaluate efficacy and safety in treating a leading cause of blindness
 » more
 1:20 min. 
April 25, 2008
Werner Wenning at the Bayer AG Annual Stockholders’ Meeting
“2007 was Bayer’s most successful year to date”
Previous year’s record levels and earnings targets exceeded / Dividend to be raised 35 percent to EUR 1.35 / Good start to fiscal 2008 / Bayer Climate Program being implemented and expanded
 » more
 1:32 min. 
Bayer off to an excellent start in 2008
Bayer Group
Annual Stockholders´ Meeting
Bayer got off to an excellent start in the first quarter of 2008, continuing last year’s positive trend in terms of both sales and earnings.
5:33 min.
 
Understanding multiple sclerosis
Research & Innovation
Understanding multiple sclerosis
The autoimmune disorder MS remains incurable. Active ingredients manufactured with biotechnological means can however delay its progression .
6:27 min.
 
New contraceptive pill in Europe
Products
New contraceptive pill in Europe
A new contraceptive pill from Bayer Schering Pharma has been granted regulatory approval by the European Commission.
1:16 min.
 
How do children perceive climate change?
Sustainability & Commitment
How do children perceive climate change?
On behalf of Bayer, photographer Peter Ginter visited eight children in their home countries. He photographed them – together with their pictures – in their natural environment.
» more
top
top
top
top
top
top
top
top
top
Search
Search
Podcast Center
Trasylol
Publications
 
Calendar
 
 
zoom - normal view 100% zoom + Textversion